5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.36%
Revenue growth above 1.5x STERV.HE's 3.30%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-7.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-22.32%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-22.32%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-22.45%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-20.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-20.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-3.06%
Share reduction while STERV.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-3.06%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
20.20%
OCF growth under 50% of STERV.HE's 126.19%. Michael Burry might suspect questionable revenue recognition or rising costs.
12.87%
FCF growth under 50% of STERV.HE's 1500.00%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-15.64%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-13.13%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
4.03%
3Y revenue/share CAGR similar to STERV.HE's 3.98%. Walter Schloss would assume both companies experience comparable short-term cycles.
272.69%
10Y OCF/share CAGR above 1.5x STERV.HE's 123.18%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
926.17%
Positive OCF/share growth while STERV.HE is negative. John Neff might see a comparative advantage in operational cash viability.
-31.90%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
141.86%
Below 50% of STERV.HE's 848.50%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
100.00%
Below 50% of STERV.HE's 1063.16%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-20.00%
Negative 3Y CAGR while STERV.HE is 70.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
22.37%
5Y equity/share CAGR above 1.5x STERV.HE's 14.86%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
22.73%
3Y equity/share CAGR similar to STERV.HE's 21.01%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
219.32%
5Y dividend/share CAGR above 1.5x STERV.HE's 36.29%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
98.48%
3Y dividend/share CAGR above 1.5x STERV.HE's 36.29%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
8.31%
AR growth well above STERV.HE's 3.03%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.36%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-6.39%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
6.92%
Positive BV/share change while STERV.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-21.68%
We’re deleveraging while STERV.HE stands at 4.63%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
6.22%
SG&A growth well above STERV.HE's 0.86%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.